DelfaGLP-1 Atlas

Lead sponsor

University Hospital, Gentofte, Copenhagen

8 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

8

Trials led

3

Active

177

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1/2
1
Phase 2
1
Phase 2/3
1
Not applicable
5

Trials by status

Recruiting
2
Active, not recruiting
1
Completed
4
Unknown
1

Trials led

DREAMBMI ≥30Ph 2Active, not recruiting54
SILENCEDBMI ≥25Ph 1/2Recruiting24
Px-LixiHealthy volunteersnot applicableCompleted24
APPBMI 18-27not applicableRecruiting18
Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.Malenot applicableCompleted15
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)BMI ≥19Ph 2/3Completed15
The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2DBMI 23-35not applicableCompleted15
GLP-1 Receptors in Normal Skin and Skin From Patients With PsoriasisBMI ≥27not applicableUnknown12